Cerebrovascular Disease in COVID-19
"> Figure 1
<p>Direct and indirect effects of COVID-19 on cerebrovascular disease. COVID-19 denotes coronavirus disease 2019. Figure generated using <a href="http://biorender.com" target="_blank">biorender.com</a>.</p> "> Figure 2
<p>Antithrombotic recommendations in patients with COVID-19. COVID-19 denotes coronavirus disease 2019. Figure generated using <a href="http://biorender.com" target="_blank">biorender.com</a>. Definitions for “critically ill” and “non-critically ill” vary between studies. Generally speaking, “critically ill” patients with COVID-19 are those who require intensive care (e.g., requiring invasive mechanical ventilation, frequent nursing assessment of vital signs, use of vasopressors, or those with multiorgan failure) or are at high risk of imminent deterioration (e.g., those with increasing oxygen requirements or with evidence of new or progressive organ dysfunction). Non-critically ill patients are those who are managed in a non-intensive medical or surgical unit or those well enough to remain outpatient.</p> ">
Abstract
:1. History of COVID-19 and Its Variants
2. Direct and Indirect Relationships between COVID-19 and Cerebrovascular Disease
3. Cerebral Vein Thrombosis
4. Antithrombotic Strategies
5. COVID-19 Impact on Stroke Systems of Care
6. Future Directions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Siegler, J.E.; Abdalkader, M.; Michel, P.; Nguyen, T.N. Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future Perspectives. J. Stroke 2022, 24, 179–188. [Google Scholar] [CrossRef]
- Rana, A.; Nguyen, T.N.; Siegler, J.E. Stroke and neurointervention in the COVID-19 pandemic: A narrative review. Expert Rev. Med. Devices 2021, 18, 523–531. [Google Scholar] [CrossRef]
- Mathieu, E.; Ritchie, H.; Rodés-Guirao, L.; Appel, C.; Giattino, C.; Hasell, J.; Macdonald, B.; Dattani, S.; Beltekian, D.; Ortiz-Ospina, E.; et al. Coronavirus Pandemic (COVID-19). Our World in Data 2020. Available online: https://ourworldindata.org/covid-cases (accessed on 18 May 2023).
- WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/ (accessed on 13 June 2023).
- Nogueira, R.G.; Qureshi, M.M.; Abdalkader, M.; Martins, S.O.; Yamagami, H.; Qiu, Z.; Mansour, O.Y.; Sathya, A.; Czlonkowska, A.; Tsivgoulis, G.; et al. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis. Neurology 2021, 96, e2824–e2838. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, T.N.; Qureshi, M.M.; Klein, P.; Yamagami, H.; Mikulik, R.; Czlonkowska, A.; Abdalkader, M.; Sedova, P.; Sathya, A.; Lo, H.C.; et al. Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: A 1-Year Follow-up. Neurology 2023, 100, e408–e421. [Google Scholar] [CrossRef] [PubMed]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
- Moghimi, N.; Di Napoli, M.; Biller, J.; Siegler, J.E.; Shekhar, R.; McCullough, L.D.; Harkins, M.S.; Hong, E.; Alaouieh, D.A.; Mansueto, G.; et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021, 21, 44. [Google Scholar] [CrossRef] [PubMed]
- Menni, C.; Valdes, A.M.; Polidori, L.; Antonelli, M.; Penamakuri, S.; Nogal, A.; Louca, P.; May, A.; Figueiredo, J.C.; Hu, C.; et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study. Lancet 2022, 399, 1618–1624. [Google Scholar] [CrossRef]
- Kläser, K.; Molteni, E.; Graham, M.; Canas, L.S.; Österdahl, M.F.; Antonelli, M.; Chen, L.; Deng, J.; Murray, B.; Kerfoot, E.; et al. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: A prospective observational cohort study. Sci. Rep. 2022, 12, 10904. [Google Scholar] [CrossRef]
- Collie, S.; Champion, J.; Moultrie, H.; Bekker, L.-G.; Gray, G. Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa. N. Engl. J. Med. 2022, 386, 494–496. [Google Scholar] [CrossRef]
- Grau, A.J.; Urbanek, C.; Palm, F. Common infections and the risk of stroke. Nat. Rev. Neurol. 2010, 6, 681–694. [Google Scholar] [CrossRef]
- Lindsberg, P.J.; Grau, A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34, 2518–2532. [Google Scholar] [CrossRef] [Green Version]
- Rasmussen, L.D.; Engsig, F.N.; Christensen, H.; Gerstoft, J.; Kronborg, G.; Pedersen, C.; Obel, N. Risk of cerebrovascular events in persons with and without HIV: A Danish nationwide population-based cohort study. AIDS 2011, 25, 1637–1646. [Google Scholar] [CrossRef] [PubMed]
- Boehme, A.K.; Luna, J.; Kulick, E.R.; Kamel, H.; Elkind, M.S.V. Influenza-like illness as a trigger for ischemic stroke. Ann. Clin. Transl. Neurol. 2018, 5, 456–463. [Google Scholar] [CrossRef] [PubMed]
- Merkler, A.E.; Parikh, N.S.; Mir, S.; Gupta, A.; Kamel, H.; Lin, E.; Lantos, J.; Schenck, E.J.; Goyal, P.; Bruce, S.S.; et al. Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs. Patients with Influenza. JAMA Neurol. 2020, 77, 1366–1372. [Google Scholar] [CrossRef] [PubMed]
- Zhang, S.; Liu, Y.; Wang, X.; Yang, L.; Li, H.; Wang, Y.; Liu, M.; Zhao, X.; Xie, Y.; Yang, Y.; et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 2020, 13, 120. [Google Scholar] [CrossRef] [PubMed]
- Varga, Z.; Flammer, A.J.; Steiger, P.; Haberecker, M.; Andermatt, R.; Zinkernagel, A.S.; Mehra, M.R.; Schuepbach, R.A.; Ruschitzka, F.; Moch, H. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020, 395, 1417–1418. [Google Scholar] [CrossRef]
- Page, E.M.; Ariëns, R.A.S. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb. Res. 2021, 200, 1–8. [Google Scholar] [CrossRef]
- Sandoval, Y.; Januzzi, J.L., Jr.; Jaffe, A.S. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J. Am. Coll. Cardiol. 2020, 76, 1244–1258. [Google Scholar] [CrossRef]
- Zhang, Y.; Xiao, M.; Zhang, S.; Xia, P.; Cao, W.; Jiang, W.; Chen, H.; Ding, X.; Zhao, H.; Zhang, H.; et al. Coagulopathy and Antiphospholipid Antibodies in Patients with COVID-19. N. Engl. J. Med. 2020, 382, e38. [Google Scholar] [CrossRef]
- Rothstein, A.; Oldridge, O.; Schwennesen, H.; Do, D.; Cucchiara, B.L. Acute Cerebrovascular Events in Hospitalized COVID-19 Patients. Stroke 2020, 51, e219–e222. [Google Scholar] [CrossRef]
- Harzallah, I.; Debliquis, A.; Drénou, B. Lupus anticoagulant is frequent in patients with COVID-19. J. Thromb. Haemost. 2020, 18, 2064–2065. [Google Scholar] [CrossRef] [PubMed]
- Siegler, J.E.; Cardona, P.; Arenillas, J.F.; Talavera, B.; Guillen, A.N.; Chavarría-Miranda, A.; de Lera, M.; Khandelwal, P.; Bach, I.; Patel, P.; et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. Int. J. Stroke 2021, 16, 437–447. [Google Scholar] [CrossRef] [PubMed]
- Lakomkin, N.; Dhamoon, M.; Carroll, K.; Singh, I.P.; Tuhrim, S.; Lee, J.; Fifi, J.T.; Mocco, J. Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke: A 10-year systematic review of the literature. J. Neurointerv. Surg. 2019, 11, 241–245. [Google Scholar] [CrossRef] [PubMed]
- Ramos-Araque, M.E.; Siegler, J.E.; Ribo, M.; Requena, M.; López, C.; de Lera, M.; Arenillas, J.F.; Pérez, I.H.; Gómez-Vicente, B.; Talavera, B.; et al. Stroke etiologies in patients with COVID-19: The SVIN COVID-19 multinational registry. BMC Neurol. 2021, 21, 43. [Google Scholar] [CrossRef]
- Siegler, J.E.; Heslin, M.E.; Thau, L.; Smith, A.; Jovin, T.G. Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center. J. Stroke Cerebrovasc. Dis. 2020, 29, 104953. [Google Scholar] [CrossRef]
- Krist, A.H.; DeVoe, J.E.; Cheng, A.; Ehrlich, T.; Jones, S.M. Redesigning Primary Care to Address the COVID-19 Pandemic in the Midst of the Pandemic. Ann. Fam. Med. 2020, 18, 349–354. [Google Scholar] [CrossRef]
- Daugherty, S.E.; Guo, Y.; Heath, K.; Dasmariñas, M.C.; Jubilo, K.G.; Samranvedhya, J.; Lipsitch, M.; Cohen, K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ 2021, 373, n1098. [Google Scholar] [CrossRef]
- Nalbandian, A.; Sehgal, K.; Gupta, A.; Madhavan, M.V.; McGroder, C.; Stevens, J.S.; Cook, J.R.; Nordvig, A.S.; Shalev, D.; Sehrawat, T.S.; et al. Post-acute COVID-19 syndrome. Nat. Med. 2021, 27, 601–615. [Google Scholar] [CrossRef]
- Knight, R.; Walker, V.; Ip, S.; Cooper, J.A.; Bolton, T.; Keene, S.; Denholm, R.; Akbari, A.; Abbasizanjani, H.; Torabi, F.; et al. Association of COVID-19 with Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation 2022, 146, 892–906. [Google Scholar] [CrossRef]
- Abdalkader, M.; Shaikh, S.P.; Siegler, J.E.; Cervantes-Arslanian, A.M.; Tiu, C.; Radu, R.A.; Tiu, V.E.; Jillella, D.V.; Mansour, O.Y.; Vera, V.; et al. Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature. J. Stroke Cerebrovasc. Dis. 2021, 30, 105733. [Google Scholar] [CrossRef]
- Klein, P.; Shu, L.; Nguyen, T.N.; Siegler, J.E.; Omran, S.S.; Simpkins, A.N.; Heldner, M.; de Havenon, A.; Aparicio, H.J.; Abdalkader, M.; et al. Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score. J. Stroke Cerebrovasc. Dis. 2022, 24, 404–416. [Google Scholar] [CrossRef] [PubMed]
- Malas, M.B.; Naazie, I.N.; Elsayed, N.; Mathlouthi, A.; Marmor, R.; Clary, B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine 2020, 29, 100639. [Google Scholar] [CrossRef] [PubMed]
- Otite, F.O.; Patel, S.; Sharma, R.; Khandwala, P.; Desai, D.; Latorre, J.G.; Akano, E.O.; Anikpezie, N.; Izzy, S.; Malik, A.M.; et al. Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States. Neurology 2020, 95, e2200–e2213. [Google Scholar] [CrossRef] [PubMed]
- Siegler, J.E.; Klein, P.; Yaghi, S.; Vigilante, N.; Abdalkader, M.; Coutinho, J.M.; Abdul Khalek, F.; Nguyen, T.N. Cerebral Vein Thrombosis with Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke 2021, 52, 3045–3053. [Google Scholar] [CrossRef]
- Dakay, K.; Cooper, J.; Bloomfield, J.; Overby, P.; Mayer, S.A.; Nuoman, R.; Sahni, R.; Gulko, E.; Kaur, G.; Santarelli, J.; et al. Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature. J. Stroke Cerebrovasc. Dis. 2021, 30, 105434. [Google Scholar] [CrossRef] [PubMed]
- McCullough-Hicks, M.E.; Halterman, D.J.; Anderson, D.; Cohen, K.; Lakshminarayan, K. High Incidence and Unique Features of Cerebral Venous Sinus Thrombosis in Hospitalized Patients with COVID-19 Infection. Stroke 2022, 53, e407–e410. [Google Scholar] [CrossRef]
- Baldini, T.; Asioli, G.M.; Romoli, M.; Carvalho Dias, M.; Schulte, E.C.; Hauer, L.; Aguiar De Sousa, D.; Sellner, J.; Zini, A. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur. J. Neurol. 2021, 28, 3478–3490. [Google Scholar] [CrossRef]
- Hinduja, A.; Nalleballe, K.; Onteddu, S.; Kovvuru, S.; Hussein, O. Impact of cerebral venous sinus thrombosis associated with COVID-19. J. Neurol. Sci. 2021, 425, 117448. [Google Scholar] [CrossRef]
- Nguyen, T.N.; Qureshi, M.M.; Klein, P.; Yamagami, H.; Abdalkader, M.; Mikulik, R.; Sathya, A.; Mansour, O.Y.; Czlonkowska, A.; Lo, H.; et al. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. J. Stroke Cerebrovasc. Dis. 2022, 24, 256–265. [Google Scholar] [CrossRef]
- Tu, T.M.; Yi, S.J.; Koh, J.S.; Saffari, S.E.; Hoe, R.H.M.; Chen, G.J.; Chiew, H.J.; Tham, C.H.; Seet, C.Y.H.; Yong, M.H.; et al. Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore. JAMA Netw. Open 2022, 5, e222940. [Google Scholar] [CrossRef]
- Sánchez van Kammen, M.; Aguiar de Sousa, D.; Poli, S.; Cordonnier, C.; Heldner, M.R.; van de Munckhof, A.; Krzywicka, K.; van Haaps, T.; Ciccone, A.; Middeldorp, S.; et al. Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021, 78, 1314–1323. [Google Scholar] [CrossRef]
- Greinacher, A.; Thiele, T.; Warkentin, T.E.; Weisser, K.; Kyrle, P.A.; Eichinger, S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N. Engl. J. Med. 2021, 384, 2092–2101. [Google Scholar] [CrossRef]
- Nicholson, M.; Goubran, H.; Chan, N.; Siegal, D. No apparent association between mRNA COVID-19 vaccination and venous thromboembolism. Blood Rev. 2022, 56, 100970. [Google Scholar] [CrossRef]
- Bikdeli, B.; Talasaz, A.H.; Rashidi, F.; Bakhshandeh, H.; Rafiee, F.; Rezaeifar, P.; Baghizadeh, E.; Matin, S.; Jamalkhani, S.; Tahamtan, O.; et al. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb. Haemost. 2022, 122, 131–141. [Google Scholar] [CrossRef]
- Buijsers, B.; Yanginlar, C.; Maciej-Hulme, M.L.; de Mast, Q.; van der Vlag, J. Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients. EBioMedicine 2020, 59, 102969. [Google Scholar] [CrossRef]
- Sholzberg, M.; Tang, G.H.; Rahhal, H.; AlHamzah, M.; Kreuziger, L.B.; Áinle, F.N.; Alomran, F.; Alayed, K.; Alsheef, M.; AlSumait, F.; et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with COVID-19 admitted to hospital: RAPID randomised clinical trial. BMJ 2021, 375, n2400. [Google Scholar] [CrossRef]
- Spyropoulos, A.C.; Goldin, M.; Giannis, D.; Diab, W.; Wang, J.; Khanijo, S.; Mignatti, A.; Gianos, E.; Cohen, M.; Sharifova, G.; et al. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients with COVID-19: The HEP-COVID Randomized Clinical Trial. JAMA Intern. Med. 2021, 181, 1612–1620. [Google Scholar] [CrossRef] [PubMed]
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with COVID-19. N. Engl. J. Med. 2021, 385, 790–802. [CrossRef] [PubMed]
- Stone, G.W.; Farkouh, M.E.; Lala, A.; Tinuoye, E.; Dressler, O.; Moreno, P.R.; Palacios, I.F.; Goodman, S.G.; Esper, R.B.; Abizaid, A.; et al. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized with COVID-19. J. Am. Coll. Cardiol. 2023, 81, 1747–1762. [Google Scholar] [CrossRef] [PubMed]
- Sholzberg, M.; da Costa, B.R.; Tang, G.H.; Rahhal, H.; AlHamzah, M.; Baumann Kreuziger, L.; Ní Áinle, F.; Almarshoodi, M.O.; James, P.D.; Lillicrap, D.; et al. Randomized trials of therapeutic heparin for COVID-19: A meta-analysis. Res. Pract. Thromb. Haemost. 2021, 5, e12638. [Google Scholar] [CrossRef] [PubMed]
- Simonetto, M.; Wechsler, P.M.; Merkler, A.E. Stroke Treatment in the Era of COVID-19: A Review. Curr. Treat. Options Neurol. 2022, 24, 155–171. [Google Scholar] [CrossRef] [PubMed]
- Cappellari, M.; Zini, A.; Sangalli, D.; Cavallini, A.; Reggiani, M.; Sepe, F.N.; Rifino, N.; Giussani, G.; Guidetti, D.; Zedde, M.; et al. Thrombolysis and bridging therapy in patients with acute ischaemic stroke and COVID-19. Eur. J. Neurol. 2020, 27, 2641–2645. [Google Scholar] [CrossRef] [PubMed]
- Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar] [CrossRef] [PubMed]
- Wang, D.; Hu, B.; Hu, C.; Zhu, F.; Liu, X.; Zhang, J.; Wang, B.; Xiang, H.; Cheng, Z.; Xiong, Y.; et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020, 323, 1061–1069. [Google Scholar] [CrossRef] [PubMed]
- Kleindorfer, D.O.; Towfighi, A.; Chaturvedi, S.; Cockroft, K.M.; Gutierrez, J.; Lombardi-Hill, D.; Kamel, H.; Kernan, W.N.; Kittner, S.J.; Leira, E.C.; et al. 2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke 2021, 52, e364–e467. [Google Scholar] [CrossRef]
- Yamakawa, M.; Kuno, T.; Mikami, T.; Takagi, H.; Gronseth, G. Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis. J. Stroke Cerebrovasc. Dis. 2020, 29, 105288. [Google Scholar] [CrossRef]
- Menezes, R.G.; Alabduladhem, T.O.; Siddiqi, A.K.; Maniya, M.T.; Al Dahlawi, A.M.; Almulhim, M.W.A.; Almulhim, H.W.; Saeed, Y.A.A.; Alotaibi, M.S.; Alarifi, S.S.; et al. Cerebrovascular disease in COVID-19: A systematic review and meta-analysis. Infez Med. 2023, 31, 140–150. [Google Scholar]
- National Institutes of Health. COVID-19 Treatment Guidelines: Antithrombotic Therapy in Patients with COVID-19. Available online: https://www.covid19treatmentguidelines.nih.gov/therapies/antithrombotic-therapy/ (accessed on 18 July 2023).
- Lang, C.N.; Dettinger, J.S.; Berchtold-Herz, M.; Utzolino, S.; Bemtgen, X.; Zotzmann, V.; Schmid, B.; Biever, P.M.; Bode, C.; Müller-Peltzer, K.; et al. Correction to: Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry Study. Neurocrit. Care 2021, 34, 1112. [Google Scholar] [CrossRef]
- Marto, J.P.; Strambo, D.; Ntaios, G.; Nguyen, T.N.; Herzig, R.; Czlonkowska, A.; Demeestere, J.; Mansour, O.Y.; Salerno, A.; Wegener, S.; et al. Safety and Outcome of Revascularization Treatment in Patients with Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry. Neurology 2023, 100, e739–e750. [Google Scholar] [CrossRef]
- Sasanejad, P.; Afshar Hezarkhani, L.; Arsang-Jang, S.; Tsivgoulis, G.; Ghoreishi, A.; Barlinn, K.; Rahmig, J.; Farhoudi, M.; Sadeghi Hokmabadi, E.; Borhani-Haghighi, A.; et al. Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative. J. Stroke Cerebrovasc. Dis. 2021, 30, 106121. [Google Scholar] [CrossRef]
- Dmytriw, A.A.; Dibas, M.; Phan, K.; Efendizade, A.; Ospel, J.; Schirmer, C.; Settecase, F.; Heran, M.K.S.; Kühn, A.L.; Puri, A.S.; et al. Acute ischaemic stroke associated with SARS-CoV-2 infection in North America. J. Neurol. Neurosurg. Psychiatry 2022, 93, 360–368. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, T.N.; Abdalkader, M.; Jovin, T.G.; Nogueira, R.G. Mechanical thrombectomy in the era of the COVID-19 pandemic: Emergency preparedness for neuroscience teams: A Guidance Statement from the Society of Vascular and Interventional Neurology. Stroke 2020, 51, 1896–1901. [Google Scholar] [CrossRef]
- Jabbour, P.; Dmytriw, A.A.; Sweid, A.; Piotin, M.; Bekelis, K.; Sourour, N.; Raz, E.; Linfante, I.; Dabus, G.; Kole, M.; et al. Characteristics of a COVID-19 Cohort with Large Vessel Occlusion: A Multicenter International Study. Neurosurgery 2022, 90, 725–733. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, T.N.; Qureshi, M.M.; Klein, P.; Yamagami, H.; Mikulik, R.; Etminan, N.; Abdalkader, M.; Mansour, O.Y.; Czlonkowska, A.; Lo, H.; et al. Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up. J. Neurol. Neurosurg. Psychiatry 2022, 93, 1028–1038. [Google Scholar]
- Nguyen, T.N.; Haussen, D.C.; Qureshi, M.M.; Yamagami, H.; Fujinaka, T.; Mansour, O.Y.; Abdalkader, M.; Frankel, M.; Qiu, Z.; Taylor, A.; et al. Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic. Stroke Vasc. Neurol. 2021, 6, 542–552. [Google Scholar] [CrossRef]
- Solomon, M.D.; McNulty, E.J.; Rana, J.S.; Leong, T.K.; Lee, C.; Sung, S.-H.; Ambrosy, A.P.; Sidney, S.; Go, A.S. The COVID-19 Pandemic and the Incidence of Acute Myocardial Infarction. N. Engl. J. Med. 2020, 383, 691–693. [Google Scholar] [CrossRef]
- Nogueira, R.G.; Etter, K.; Nguyen, T.N.; Ikeme, S.; Wong, C.; Frankel, M.; Haussen, D.C.; Del Rio, C.; McDaniel, M.; Sachdeva, R.; et al. Changes in the care of acute cerebrovascular and cardiovascular conditions during the first year of the COVID-19 pandemic in 746 hospitals in the USA: Retrospective analysis. BMJ Med. 2023, 2, e000207. [Google Scholar] [CrossRef]
- Rosenthal, M.G.; Fakhry, S.M.; Morse, J.L.; Wyse, R.J.; Garland, J.M.; Duane, T.M.; Slivinski, A.; Wilson, N.Y.; Watts, D.D.; Shen, Y.; et al. Where did all the appendicitis go? Impact of the COVID-19 pandemic on volume, management, and outcomes of acute appendicitis in a nationwide, multicenter analysis. Ann. Surg. Open 2021, 2, e048. [Google Scholar] [CrossRef]
- Gale, R.; Eberlein, S.; Fuller, G.; Khalil, C.; Almario, C.V.; Spiegel, B.M.R. Public Perspectives on Decisions About Emergency Care Seeking for Care Unrelated to COVID-19 During the COVID-19 Pandemic. JAMA Netw. Open 2021, 4, e2120940. [Google Scholar] [CrossRef]
- Zhao, J.; Li, H.; Kung, D.; Fisher, M.; Shen, Y.; Liu, R. Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions. Stroke 2020, 51, 1996–2001. Available online: https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.120.030225 (accessed on 18 July 2023). [CrossRef]
- Czeisler, M.É.; Marynak, K.; Clarke, K.E.N.; Salah, Z.; Shakya, I.; Thierry, J.M.; Ali, N.; McMillan, H.; Wiley, J.F.; Weaver, M.D.; et al. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns—United States, June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1250–1257. [Google Scholar] [CrossRef]
- Olsen, S.J.; Winn, A.K.; Budd, A.P.; Prill, M.M.; Steel, J.; Midgley, C.M.; Kniss, K.; Burns, E.; Rowe, T.; Foust, A.; et al. Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic—United States, 2020–2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 1013–1019. [Google Scholar] [CrossRef] [PubMed]
- Cassell, K.; Zipfel, C.M.; Bansal, S.; Weinberger, D.M. Trends in non-COVID-19 hospitalizations prior to and during the COVID-19 pandemic period, United States, 2017–2021. Nat. Commun. 2022, 13, 5930. [Google Scholar] [CrossRef]
- Hartnett, K.P.; Kite-Powell, A.; DeVies, J.; Coletta, M.A.; Boehmer, T.K.; Adjemian, J.; Gundlapalli, A.V.; National Syndromic Surveillance Program Community of Practice. Impact of the COVID-19 Pandemic on Emergency Department Visits—United States, January 1, 2019–May 30, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 699–704. [Google Scholar] [CrossRef]
- Siegler, J.E.; Zha, A.M.; Czap, A.L.; Ortega-Gutierrez, S.; Farooqui, M.; Liebeskind, D.S.; Desai, S.M.; Hassan, A.E.; Starosciak, A.K.; Linfante, I.; et al. Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke: The Society of Vascular and Interventional Neurology Multicenter Collaboration. Stroke 2020, 52, 40–47. [Google Scholar] [CrossRef] [PubMed]
- Alonso de Leciñana, M.; Castellanos, M.; Ayo-Martín, Ó.; Morales, A.; Stroke Group—Spanish Society of Neurology. Stroke care during the COVID-19 outbreak in Spain: The experience of Spanish stroke units. Stroke Vasc. Neurol. 2021, 6, 267–273. [Google Scholar] [CrossRef] [PubMed]
- Rivera, R.; Amudio, C.; Cruz, J.P.; Brunetti, E.; Catalan, P.; Sordo, J.G.; Echeverria, D.; Badilla, L.; Chamorro, A.; Gonzalez, C.; et al. The impact of a two-year long COVID-19 public health restriction program on mechanical thrombectomy outcomes in a stroke network. J. Stroke Cerebrovasc. Dis. 2023, 32, 107138. [Google Scholar] [CrossRef]
- Jillella, D.V.; Nahab, F.; Nguyen, T.N.; Abdalkader, M.; Liebeskind, D.S.; Vora, N.; Rai, V.; Haussen, D.C.; Nogueira, R.G.; Desai, S.; et al. Delays in thrombolysis during COVID-19 are associated with worse neurological outcomes: The Society of Vascular and Interventional Neurology Multicenter Collaboration. J. Neurol. 2022, 269, 603–608. [Google Scholar] [CrossRef]
- Khandelwal, P.; Al-Mufti, F.; Tiwari, A.; Singla, A.; Dmytriw, A.A.; Piano, M.; Quilici, L.; Pero, G.; Renieri, L.; Limbucci, N.; et al. Incidence, Characteristics and Outcomes of Large Vessel Stroke in COVID-19 Cohort: An International Multicenter Study. Neurosurgery 2021, 89, E35–E41. [Google Scholar] [CrossRef]
- Czap, A.L.; Zha, A.M.; Sebaugh, J.; Hassan, A.E.; Shulman, J.G.; Abdalkader, M.; Nguyen, T.N.; Linfante, I.; Starosciak, A.K.; Ortega-Gutierrez, S.; et al. Endovascular thrombectomy time metrics in the era of COVID-19: Observations from the Society of Vascular and Interventional Neurology Multicenter Collaboration. J. Neurointerv. Surg. 2022, 14, neurintsurg-2020-017205. [Google Scholar] [CrossRef]
- Raymaekers, V.; Demeestere, J.; Bellante, F.; De Blauwe, S.; De Raedt, S.; Dusart, A.; Jodaitis, L.; Lemmens, R.; Loos, C.; Noémie, L.; et al. The impact of COVID-19 on acute stroke care in Belgium. Acta Neurol. Belg. 2021, 121, 1251–1258. [Google Scholar] [CrossRef] [PubMed]
- AHA/ASA Stroke Council Leadership. Temporary Emergency Guidance to US Stroke Centers during the Coronavirus Disease 2019 (COVID-19) Pandemic: On Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke 2020, 51, 1910–1912. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nguyen, T.N.; Jadhav, A.P.; Dasenbrock, H.H.; Nogueira, R.G.; Abdalkader, M.; Ma, A.; Cervantes-Arslanian, A.M.; Greer, D.M.; Daneshmand, A.; Yavagal, D.R.; et al. Subarachnoid hemorrhage guidance in the era of the COVID-19 pandemic—An opinion to mitigate exposure and conserve personal protective equipment. J. Stroke Cerebrovasc. Dis. 2020, 29, 105010. [Google Scholar] [CrossRef] [PubMed]
- Abdalkader, M.; Sathya, A.; Malek, A.M.; Fifi, J.T.; Norbash, A.M.; Wakhloo, A.K.; Nguyen, T.N. Roadmap for Resuming Elective Neuroendovascular Procedures Following the First COVID-19 Surge. J. Stroke Cerebrovasc. Dis. 2020, 29, 105177. [Google Scholar] [CrossRef] [PubMed]
- Thau, L.; Siegal, T.; Heslin, M.E.; Rana, A.; Yu, S.; Kamen, S.; Chen, A.; Vigilante, N.; Gallagher, S.; Wegner, K.; et al. Decline in Rehab Transfers among Rehab-Eligible Stroke Patients during the COVID-19 Pandemic. J. Stroke Cerebrovasc. Dis. 2021, 30, 105857. [Google Scholar] [CrossRef] [PubMed]
- Ortega-Gutierrez, S.; Farooqui, M.; Zha, A.; Czap, A.; Sebaugh, J.; Desai, S.; Jadhav, A.; Vora, N.; Rai, V.; Jovin, T.G.; et al. Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic: The Society of vascular and Interventional Neurology multicenter collaboration. Clin. Neurol. Neurosurg. 2021, 201, 106436. [Google Scholar] [CrossRef]
- Roberts, P.; Wertheimer, J.; Park, E.; Nuño, M.; Riggs, R. Identification of Functional Limitations and Discharge Destination in Patients with COVID-19. Arch. Phys. Med. Rehabil. 2021, 102, 351–358. [Google Scholar] [CrossRef]
- Maltser, S.; Trovato, E.; Fusco, H.N.; Sison, C.P.; Ambrose, A.F.; Herrera, J.; Murphy, S.; Kirshblum, S.; Bartels, M.N.; Bagay, L.; et al. Challenges and Lessons Learned for Acute Inpatient Rehabilitation of Persons with COVID-19: Clinical Presentation, Assessment, Needs, and Services Utilization. Am. J. Phys. Med. Rehabil. 2021, 100, 1115–1123. [Google Scholar] [CrossRef]
- Spanko, A. Nursing Home Industry Projects $34B in Revenue Losses, 1800 Closures or Mergers due to COVID. Skilled Nurs. News 2021. Available online: https://skillednursingnews.com/2021/02/nursing-home-industry-projects-34b-in-revenue-losses-1800-closures-or-mergers-due-to-covid/ (accessed on 1 May 2023).
- Hubert, G.J.; Corea, F.; Schlachetzki, F. The role of telemedicine in acute stroke treatment in times of pandemic. Curr. Opin. Neurol. 2021, 34, 22–26. [Google Scholar] [CrossRef]
- Miller, A.; Segan, S.; Rehmani, R.; Shabsigh, R.; Rahme, R. Letter: Dismantling the Apocalypse Narrative: The Myth of the COVID-19 Stroke. Neurosurgery 2020, 87, E703–E704. [Google Scholar] [CrossRef]
- Chavda, V.P.; Chen, Y.; Dave, J.; Chen, Z.-S.; Chauhan, S.C.; Yallapu, M.M.; Uversky, V.N.; Bezbaruah, R.; Patel, S.; Apostolopoulos, V. COVID-19 and vaccination: Myths vs science. Expert Rev. Vaccines 2022, 21, 1603–1620. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Siegler, J.E.; Dasgupta, S.; Abdalkader, M.; Penckofer, M.; Yaghi, S.; Nguyen, T.N. Cerebrovascular Disease in COVID-19. Viruses 2023, 15, 1598. https://doi.org/10.3390/v15071598
Siegler JE, Dasgupta S, Abdalkader M, Penckofer M, Yaghi S, Nguyen TN. Cerebrovascular Disease in COVID-19. Viruses. 2023; 15(7):1598. https://doi.org/10.3390/v15071598
Chicago/Turabian StyleSiegler, James E., Savanna Dasgupta, Mohamad Abdalkader, Mary Penckofer, Shadi Yaghi, and Thanh N. Nguyen. 2023. "Cerebrovascular Disease in COVID-19" Viruses 15, no. 7: 1598. https://doi.org/10.3390/v15071598